Skip to main content

Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Stifel 2023 Healthcare Conference
Fireside Chat: Tuesday, November 14, 2023 at 3:35 pm ET
Location: Lotte New York Palace Hotel, New York, NY

A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.

6th Annual Evercore ISI HealthCONx Conference
Fireside Chat: Wednesday, November 29, 2023 at 3:00 pm ET
Location: Kimpton EPIC Hotel, Miami, FL

Piper Sandler 35th Annual Healthcare Conference
Fireside Chat: Thursday, November 30, 2023 at 2:00 pm ET
Location: Lotte New York Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com

 


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  202.46
+3.12 (1.57%)
AAPL  246.90
-1.90 (-0.76%)
AMD  196.95
-5.04 (-2.50%)
BAC  47.34
+0.37 (0.79%)
GOOG  273.44
-0.31 (-0.12%)
META  537.29
+11.57 (2.20%)
MSFT  360.63
+3.86 (1.08%)
NVDA  166.12
-1.40 (-0.84%)
ORCL  138.71
-0.95 (-0.68%)
TSLA  358.33
-3.50 (-0.97%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.